Why I’m Offering DMPA to Patients With Uterine Fibroids

Why I’m Offering DMPA to Patients With Uterine Fibroids

This transcript has been edited for clarity. Hello. I’m Andrew Kaunitz, professor and associate chair in the Ob/Gyn Department, University of Florida College of Medicine, Jacksonville. Today, I’d like to discuss depot medroxyprogesterone acetate (DMPA) and uterine fibroids. Uterine leiomyoma (fibroids) is the most common gynecologic tumor. The prevalence is particularly high among Black women. …

Why I’m Offering DMPA to Patients With Uterine Fibroids Read More »